HealthcareChief

HealthcareChief Leading online publication for healthcare industry executives

Field Medical has secured an additional $35 million in venture capital investment for its heart pulse field ablation dev...
07/08/2025

Field Medical has secured an additional $35 million in venture capital investment for its heart pulse field ablation device to facilitate the initiation of a key study. The FieldForce pulsed field ablation (PFA) system includes the first purpose-built, contact force, focused PFA catheter. It facilitates an immediate ablation process. The business obtained FDA innovative device status for FieldForce at the tail-end of 2024.

Beacon Health System has completed its acquisition of Ascension’s Southwest Michigan Region, officially incorporating fo...
07/05/2025

Beacon Health System has completed its acquisition of Ascension’s Southwest Michigan Region, officially incorporating four hospitals, 35 outpatient clinics, an ambulatory surgery center, and more than 2,700 employees into its operations. The transaction, originally announced in early April, marks Beacon’s first expansion into Michigan, extending the Indiana-based nonprofit’s reach to a total of 11 hospitals and nearly 190 care sites staffed by close to 11,000 individuals.

Novo Nordisk has officially ended its collaboration with the telehealth provider hims & hers over issues related to the ...
06/24/2025

Novo Nordisk has officially ended its collaboration with the telehealth provider hims & hers over issues related to the marketing and sale of compounded versions of the weight-loss drug Wegovy®(semaglutide) injection 2.4 mg HCP. The termination follows concerns raised by Novo Nordisk that Hims & Hers continued promoting unauthorized alternatives to Wegovy, despite regulatory changes stemming from the resolution of a prior shortage of the drug.

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has rele...
06/23/2025

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has released a revised agenda for its upcoming June 25–26 meeting, indicating a shift in focus and priorities under new leadership. The changes follow an overhaul of the panel by Robert F. Kennedy Jr., who now leads the Department of Health and Human Services (HHS).

Apitegromab–tirzepatide combo reduces lean mass loss in obesity patients, providing a new edge in weight loss drug devel...
06/20/2025

Apitegromab–tirzepatide combo reduces lean mass loss in obesity patients, providing a new edge in weight loss drug development

In a promising development for the obesity drug market, Scholar Rock’s investigational SMA treatment apitegromab has shown potential to help Zepbound (tirzepatide) patients preserve lean muscle mass during weight loss. These findings from a Phase 2 clinical trial suggest a new therapeutic opportunity beyond spinal muscular atrophy (SMA).

Cigna announced the launch of new digital tools designed to improve how members navigate their health benefits. The init...
06/18/2025

Cigna announced the launch of new digital tools designed to improve how members navigate their health benefits. The initiative includes a virtual assistant powered by generative artificial intelligence and several features aimed at streamlining access to coverage and care.

The World Health Organization reports a growing cholera outbreak across Sudan, warning of potential cross-border transmi...
06/17/2025

The World Health Organization reports a growing cholera outbreak across Sudan, warning of potential cross-border transmission to Chad and Libya amid conflict, displacement, and lack of clean water.

Eli Lilly has announced new pricing measures across its Zepbound obesity medication line, including reductions for its t...
06/17/2025

Eli Lilly has announced new pricing measures across its Zepbound obesity medication line, including reductions for its two highest marketed doses. The company stated that the 12.5 mg and 15 mg strengths of Zepbound will be offered in single-dose vials for $499 per month via its LillyDirect self-pay platform.

The dismissal of all 17 current members of a crucial vaccination advisory group by Department of Health and Human Servic...
06/14/2025

The dismissal of all 17 current members of a crucial vaccination advisory group by Department of Health and Human Services Secretary Robert F. Kennedy Jr. has provoked outrage from medical organizations and specialists, alongside reservations over the reliability of the anticipated successors.

Attorneys general from New York, California, Massachusetts, and New Jersey have submitted a formal petition to the Food ...
06/13/2025

Attorneys general from New York, California, Massachusetts, and New Jersey have submitted a formal petition to the Food and Drug Administration (FDA), asking the agency to remove restrictions on the abortion medication mifepristone.

Omada Health, a virtual chronic care provider, priced its initial public offering at $19 per share, landing at the midpo...
06/12/2025

Omada Health, a virtual chronic care provider, priced its initial public offering at $19 per share, landing at the midpoint of its $18 to $20 per share range. The company raised $150 million through the sale of 7.9 million shares of common stock.

Neuralink has announced that it has successfully closed a Series E funding round, raising a total of $650 million to sup...
06/09/2025

Neuralink has announced that it has successfully closed a Series E funding round, raising a total of $650 million to support its ongoing work. According to a blog post released by the company, the funds will be used to expand patient access to its brain-computer interface (BCI) technology and to further the development of new devices designed to advance its capabilities.

Address

Newark, NJ

Website

Alerts

Be the first to know and let us send you an email when HealthcareChief posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category